Sarah Romano - Feb 10, 2022 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role: Chief Financial Officer
Signature: /s/ Sarah Romano
Stock symbol: KPRX
Transactions as of: Feb 10, 2022
Transactions value $: -$75
Form type: 4
Date filed: 2/11/2022, 03:31 PM
Previous filing: Feb 3, 2022
Next filing: Mar 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KPRX	Common Stock	Tax liability	-$75	-108	-0.47%	$0.69	22.7K	Feb 10, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Sale of shares to cover taxes due on restricted stock that vested on 02/01/2022.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.70, inclusive. The reporting person hereby undertakes to provide to Kiora Pharmaceuticals, Inc., any security holder of Kiora Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Content

Sale of shares to cover taxes due on restricted stock that vested on 02/01/2022.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.70, inclusive. The reporting person hereby undertakes to provide to Kiora Pharmaceuticals, Inc., any security holder of Kiora Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.